Montelukast%252525252525252525252525252525252525252525252525252525252520levocetrizine

# Montelukast/Levocetirizine ## Overview Montelukast is a leukotriene receptor antagonist. Levocetirizine is a second-generation antihistamine. This combination is used for the management of allergic rhinitis. ## Primary Indications * Allergic rhinitis (seasonal and perennial) ## Adult Dosing * The standard dose is montelukast 10 mg orally once daily and levocetirizine 5 mg orally once daily. * Dosing is typically taken in the evening. ## Pediatric Dosing * **Montelukast:** * 6 months to 5 years: 4 mg orally once daily. * 6 to 14 years: 5 mg orally once daily. * 15 years and older: 10 mg orally once daily. * **Levocetirizine:** * 6 to 11 years: 2.5 mg orally once daily. * 12 years and older: 5 mg orally once daily. * **Combination Product:** Refer to specific product labeling for age-appropriate combination formulations. Fixed-dose combinations may not be available for all pediatric age groups. ## Dose Adjustments * **Hepatic Impairment:** Use with caution; no specific dose adjustments are universally established for the combination. Montelukast: Reduction may be considered. Levocetirizine: Reduce dose to 2.5 mg once daily in moderate to severe hepatic impairment. * **Renal Impairment:** Use with caution; no specific dose adjustments are universally established for the combination. Levocetirizine: Reduce dose based on degree of renal impairment (e.g., CrCl 30-49 mL/min: 2.5 mg every other day; CrCl 10-29 mL/min: 2.5 mg twice weekly). ## Contraindications * Hypersensitivity to montelukast, levocetirizine, or any component of the formulation. * Severe hepatic impairment (for montelukast). ## Adverse Effects * **Common:** Somnolence, fatigue, dizziness, headache, dry mouth, pharyngitis, cough, upper respiratory tract infection. * **Serious:** Neuropsychiatric events (agitation, aggression, suicidal thoughts, depression, hallucinations, insomnia) associated with montelukast; angioedema, severe skin reactions. ## Key Drug Interactions * **Theophylline:** Montelukast may increase theophylline concentrations. Monitor theophylline levels. * **Sedating Medications:** Additive sedative effects with CNS depressants, alcohol, and other sedating antihistamines. * **CYP1A2/3A4 Inhibitors/Inducers:** Potential for altered concentrations of montelukast, though clinically significant interactions are uncommon. * **Phenobarbital/Rifampin:** May increase the metabolism of montelukast, reducing efficacy. ## Monitoring * Monitor for therapeutic response. * Monitor for adverse effects, particularly neuropsychiatric changes with montelukast. * Monitor renal function if indicated for levocetirizine dose adjustment. ## Clinical Pearls * Montelukast/levocetirizine combination offers a convenient dosing regimen for patients with allergic rhinitis. * Ensure patients are aware of potential neuropsychiatric side effects associated with montelukast and to report them immediately. * Levocetirizine can cause significant drowsiness; advise patients to avoid operating heavy machinery or complex tasks until they know how it affects them. * Administer montelukast in the evening, as it has a circadian rhythm activity. *** **Disclaimer:** This information is intended for healthcare professionals and does not replace detailed prescribing information. Always verify current prescribing information and local guidelines before making any clinical decisions.